Corpus Intelligence IC Memo — WAKEMED RALEIGH CAMPUS 2026-04-26 05:06 UTC
IC Memo — WAKEMED RALEIGH CAMPUS
Investment Committee Memorandum | NC | 609 beds | Grade C | EBITDA uplift $84.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WAKEMED RALEIGH CAMPUS

CCN 340069 | WAKE, NC | 609 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WAKEMED RALEIGH CAMPUS is a 609-bed large academic medical center in WAKE, NC with $1.15B in net patient revenue and a -1.4% operating margin. The hospital serves a payer mix of 19.4% Medicare, 9.7% Medicaid, and 70.9% commercial.

Thesis: Undervalued. Our ML models identify $84.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.4% to 5.9% (+736bps).

Net Revenue HCRIS$1.15B
Current EBITDA COMPUTED$-16.5M
Operating Margin COMPUTED-1.4%
Occupancy HCRIS92.3%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS24.6%
Distress Probability ML39.6%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
22
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -1.4% places it above the state median. Among 22 size-comparable peers (304-1218 beds), the median margin is -2.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (304-1218), prioritizing same-state peers. 22 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WAKEMED RALEIGH CAMPUS (Target)NC609$1.15B-1.4%
DUKE UNIVERSITY HOSPITALNC1048$3.16B-4.5%
CAROLINAS MEDICAL CENTERNC1142$3.03B-5.5%
UNIVERSITY OF NORTH CAROLINA HNC799$2.88B13.3%
NORTH CAROLINA BAPTIST HOSPITANC800$2.19B-4.7%
REX HOSPITALNC489$1.51B-0.8%
PITT COUNTY MEMORIAL HOSPITALNC1013$1.38B-3.0%
FORSYTH MEMORIAL HOSPITAL INCNC906$1.36B-7.1%
PRESBYTERIAN HOSPITALNC561$1.33B1.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $84.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$24.1M+210bp18mo
Cost to Collect4.5%2.5%$22.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$22.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$14.0M+122bp9mo
Clean Claim Rate88.0%96.0%$734K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$24.1M
Cost to Collect
$22.9M
Denial Rate Reduction
$22.7M
A/R Days Reduction
$14.0M
Clean Claim Rate
$734K
Total EBITDA Uplift$84.4M
Current EBITDA$-16.5M
+ RCM Uplift+$84.4M
Pro Forma EBITDA$68.0M
Current Margin-1.4%
Pro Forma Margin5.9%
WC Released (1x)$44.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-25.3M$735.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-25.3M$800.9M0.00x-100.0%
Bull Case9.0x11.0x$-22.8M$1.07B0.00x-100.0%
Bull (12x exit)9.0x12.0x$-22.8M$1.16B0.00x-100.0%
Bear Case11.0x10.0x$-27.9M$321.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-27.9M$344.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 22 hospitals with 304-1218 beds
  • Same-state prioritization (n=23)
  • Comp margins: P25=-5.5% / P50=-2.9% / P75=7.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.